Axial Spondyloarthritis

A 5-year study of bimekizumab in ankylosing spondylitis encountered no new safety signals, with efficacy sustained even in a conservative analysis with non-responder imputation, according to data published in RMD Open.

TNF inhibitors for the treatment of axial spondyloarthritis may decrease the risk for hip or spine fracture by as much as 29% compared with NSAIDs, according to data published in Arthritis & Rheumatology.

Women with axial spondyloarthritis face longer diagnostic delays and greater disease burden than men despite higher rates of treatment and healthy behaviors, according to data published in International Journal of Rheumatic Diseases.

“Ankylosing spondylitis”? “Sjögren’s syndrome”?

Ethan Craig, MD, spoke with Healio about treatment options coming up in the pipeline for psoriatic arthritis.

Ethan Craig, MD, spoke with Healio about diagnostic challenges in psoriatic arthritis.

Smoking, substance use disorder and taking gabapentinoids or antidepressants predict long-term opioid use among patients with axial spondyloarthritis and psoriatic arthritis, according to data published in Rheumatology.

Increasing the dosage of secukinumab failed to improve ankylosing spondylitis outcomes among patients who initially demonstrated an inadequate treatment response, according to data published in Rheumatology.

ORLANDO, Fla. — Understanding the nuances of spondyloarthropathy diagnostic criteria can help prevent “debilitating” consequences, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.